|
Characterization of tumor microenvironment in extraskeletal myxoid chondrosarcoma (EMC). |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Lilly; Novartis; Pfizer; PharmaMar |
Consulting or Advisory Role - Bayer; Lilly; Nanobiotix; Novartis; Pfizer; PharmaMar |
Research Funding - PharmaMar (Inst) |
Travel, Accommodations, Expenses - Nanobiotix; PharmaMar |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Amgen |
Travel, Accommodations, Expenses - Pharmamar; takeda |
|
|
Honoraria - Novartis; Pfizer; PharmaMar |
Consulting or Advisory Role - ARIAD/Merck; Bayer; Blueprint Medicines; Eisai; GlaxoSmithKline; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; PharmaMar |
Research Funding - Amgen/Dompé (Inst); Bayer (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MolMed (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst) |
Travel, Accommodations, Expenses - PharmaMar |
|
|
Speakers' Bureau - Jazz Pharmaceuticals |
Patents, Royalties, Other Intellectual Property - Biogenera |
Travel, Accommodations, Expenses - Genzyme |
|
|
Consulting or Advisory Role - Bayer; Pfizer |
Speakers' Bureau - Pfizer |
Research Funding - Novartis |
|
|
Honoraria - Lilly; PharmaMar; Takeda |
Consulting or Advisory Role - Bayer; Epizyme; Immune Design; Lilly; MaxiVax; PharmaMar |
Research Funding - Advenchen Laboratories (Inst); Amgen (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst) |
Travel, Accommodations, Expenses - PharmaMar |